Here are the principal “slide deck” visuals used to introduce Imagion Biosystems to investors prior to the company’s initial public offering on the Australian Securities Exchange. (download
This year’s Annual Meeting of the American Association for Cancer Research was held April 1-5 in Washington, D.C. The theme of this year’s meeting was
For effective use in detecting specific types of cancer, tumor-targeting nanoparticles must evade the immune system, remain intact for a clinically relevant time frame, and
Rebeca Romero Aburto PhD is an Imagion Biosystems research collaborator and a post-doctoral fellow at the University of Texas MD Anderson Cancer Center. As an